Insulin Degludec Aspart: The First Co-Formulation of Insulin Analogues

Diabetes Therapy - United States
doi 10.1007/s13300-014-0067-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Comparison of a Soluble Co-Formulation of Insulin Degludec/Insulin Aspart vs Biphasic Insulin Aspart 30 in Type 2 Diabetes: A Randomised Trial

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2012English

Fiasp: A New Faster-Acting Insulin Aspart Formulation for Diabetes

Prescriber
Pharmacology
2017English

The Human Insulin Analog Aspart Can Induce Insulin Allergy

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2004English

Insulin Aspart Reduziert Kardiovaskuläre Ereignisse

MMW Fortschritte der Medizin
Medicine
2016English

Initiation of Biphasic Insulin Aspart in a Patient Failing Basal Insulin Treatment

European Endocrinology
EndocrineEndocrinologyMetabolismAutonomic SystemsDiabetes
2010English

Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2005English

Besser Und Kostengünstiger Mit Insulin Aspart

MMW Fortschritte der Medizin
Medicine
2017English

Use of Fast‐acting Insulin Aspart in Insulin Pump Therapy in Clinical Practice

Diabetes, Obesity and Metabolism
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Mechanism of Action of Insulin and Insulin Analogues

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1981English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy